Pfizer and Concerto HealthAI partner to develop cancer therapies
Concerto HealthAI (MA, USA) has entered into collaboration with Pfizer (NY, USA), to make use of real-world data and provide actionable patient insights for Pfizer’s investigational therapies and commercialized therapeutics used to treat solid tumors and hematologic malignancies.
Please sign in or register for FREE
Sign in to The Evidence Base®
Did you know?
Your The Evidence Base™ account also gives you access to communities on regenerative medicine, real-world evidence and drug discovery. Find out more>>